Actn3 Bioinformatics sp. z o.o.

Computer programming activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-08-23
Share capital
5,000.00 PLN
Activity description

Actn3 Bioinformatics is a company that provides professional bioinformatics services for the biotech and pharmaceutical industries, specializing in next-generation sequencing (NGS) analysis, R package development, and pipeline development. They offer end-to-end sequencing analysis, custom Bioconductor packages, and production-ready workflows, with a focus on regulatory compliance and reproducibility. With over 9 years of experience and 800+ samples analyzed, they deliver publication-ready insights and AI-powered solutions.

Registered address
ul. 11 Listopada 187/5, 41-219 Sosnowiec, Poland
Website
Email
Social media

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 91 days early.

  • 202501/07/2026
  • 202413/02/2025
  • 202327/06/2024
  • 202231/03/2023
  • 202101/06/2022
  • 202019/03/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Computer programming activities8,039 / 11,174
Top 72%
Sector · Information and communication14,965 / 21,342
Top 70%
City · Sosnowiec805 / 972
Top 83%
Voivodeship · Śląskie26,493 / 33,177
Top 80%
Country · Poland235,244 / 297,266
Top 79%

Results vs industry

Revenue
This companyUSD 34.25kMedianUSD 120.54kAverageUSD 1.77m
Net profit
This companyUSD -11.18kMedianUSD 2.92kAverageUSD 23.81k
Operating costs
This companyUSD 45.43kMedianUSD 112.29kAverageUSD 1.69m
Assets
This companyUSD 1.30kMedianUSD 79.64kAverageUSD 1.14m

Offer

Websites

  • actn3.plACTN3 Bioinformatics | Bioinformatics Services
    LiteSpeed

Authorized Representatives

Szymon Myrta age 38 – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
10$135.0610%
90$1,215.5690%

Szymon Myrta and Maria Dorota Myrta hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-08-30.

  • mBank
    11 1140 2004 0000 3302 7796 1084

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Nexbio sp. z o.o.
Intelliseq S.A.
Xenstats sp. z o.o.
Digital Pathology Team sp. z o.o.
Svexa Poland sp. z o.o.
Personather sp. z o.o.
Aprodata P.S.A.
Data2biology sp. z o.o.
Anthillo sp. z o.o.
Bioinfo Capital sp. z o.o.

FAQ

Last updated: 2026-07-04